Interestingly, BTEC migration was significantly decreased by activation of EPAC-1, a downstream target or cAMP, accordingly with the ability of EPAC-1 to inhibit migration reported on different cell types, including cancer cells32, 33. The gene discussed is RAPGEF3; the disease is cancer.